Description
2.5 mg dutasteride grows more hair than any other dose tested. So why wouldn't I take it?
Rob English from Perfect Hair Health recently called 2.5 mg oral dutasteride possibly the most powerful treatment for male pattern hair loss. He's mostly right about the data. In this video, I break down what that data does NOT cover: side effects, fertility, how long it stays in your body, and what else 5-alpha reductase does beyond making DHT. Then I share the strategy I use instead.
👉 Work with me 1:1 (limited spots): https://letsgethair.com/mentorship
👉 Free hair transplant plan: https://letsgethair.com/quiz/?utm_source=yt-lgh-dscr-outcome
━━━━━━━━━━━━━━━━━━━━
CHAPTERS
━━━━━━━━━━━━━━━━━━━━
Is 2.5 mg dutasteride the most effective hair loss treatment? I break down the data to show why I choose a different strategy.
Rob English recently highlighted the potential of high-dose dutasteride for male pattern hair loss. While the data on hair growth is compelling, it often ignores critical factors like fertility, neurosteroid impact, and long-term side effects. This video examines what the clinical trials actually say about these risks versus the potential benefits.
I also walk through my personal protocol, explaining why I rely on finasteride instead of jumping to a higher dose. We cover the hormonal trade-offs, prostate screening, and the recovery timeline after stopping medication. If you are debating your own hair loss regimen, this breakdown helps clarify the difference between chasing maximum growth and maintaining long-term health.
Subscribe for weekly hair loss treatment breakdowns, and comment below if you have questions about your own protocol.
00:00 Is 2.5 mg Dutasteride the Strongest Hair Loss Treatment?
01:40 The 2006 Study: 2.5 mg vs 0.5 mg Dutasteride
03:09 Hair Growth Results vs Side Effects
04:21 Why Wasn't 2.5 mg Approved for Hair Loss?
06:01 Dutasteride's Impact on Fertility and Sperm Count
07:18 Beyond DHT: What Else Does Dutasteride Block?
08:34 Allopregnanolone and Neurosteroids
09:34 Cortisol, Insulin Sensitivity and Body Fat
11:06 Steroid Metabolism and Recovery After Stopping
12:19 Dutasteride and Dry Eyes
12:56 Why I Still Take Finasteride Instead of Dutasteride
16:12 PSA Suppression and Prostate Screening
17:08 My Own Fertility and Sperm Count Results
18:07 Who Should Consider 2.5 mg Dutasteride?
19:02 My Long-Term Hair Loss Treatment Strategy
21:33 Get Help Building Your Hair Loss Plan
━━━━━━━━━━━━━━━━━━━━
STUDIES & SOURCES
━━━━━━━━━━━━━━━━━━━━
Rob English's video on 2.5 mg dutasteride:
https://www.youtube.com/watch?v=daOyk4uRbC4&t=29s
The 2.5 mg trial (Olsen et al., 2006):
https://doi.org/10.1016/j.jaad.2006.05.007
Japanese regulator (PMDA) review of dutasteride for hair loss, 2015 (reanalysed hair, side-effect, blood-level and DHT data from the 2.5 mg trial; approval at 0.1 mg / 0.5 mg):
https://www.pmda.go.jp/files/000245812.pdf
Phase III trial, dutasteride 0.5 mg vs finasteride 1 mg (Gubelin Harcha et al., 2014):
https://pubmed.ncbi.nlm.nih.gov/24411083/
Korean phase III trial (dutasteride 0.5 mg):
https://clinicaltrials.gov/study/NCT00441116
Semen parameters on dutasteride and finasteride (Amory et al., 2007):
https://pubmed.ncbi.nlm.nih.gov/17299062/
Erratum: https://doi.org/10.1210/jcem.92.11.9991
Dutasteride prescribing information (US label):
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e537c60d-9ba2-4e7f-a405-2b915dcd7ead
Allopregnanolone and dutasteride in women with PMDD (Martinez et al., 2016):
https://pubmed.ncbi.nlm.nih.gov/26272051/
Insulin sensitivity and cortisol metabolism (Upreti et al., 2014):
https://pubmed.ncbi.nlm.nih.gov/24823464/
Urinary steroid metabolites on and after dutasteride (Maeda et al., 2018):
https://doi.org/10.1016/j.clinbiochem.2018.03.021
FDA adverse event reports analysis incl. dry eye signal (The Aging Male, 2026):
https://doi.org/10.1080/13685538.2026.2647019
Macular abnormalities associated with 5-alpha reductase inhibitors (Shin et al., JAMA Ophthalmology, 2020):
https://pubmed.ncbi.nlm.nih.gov/32379286/
Twice- or thrice-weekly dutasteride vs daily finasteride, pilot study (2025):
https://www.sciencedirect.com/science/article/pii/S2666328725001014